CG MedTech Co.,Ltd. (KOSDAQ:056090)

Market Cap	223.04B +141.1%
Revenue (ttm)	47.23B +36.4%
Net Income	6.51B +10,801.8%
EPS	63.00 +6,200.0%
Shares Out	103.26M
PE Ratio	34.29
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,258,680
Average Volume	4,188,047
Open	2,265.00
Previous Close	2,255.00
Day's Range	2,090.00 - 2,290.00
52-Week Range	866.00 - 3,555.00
Beta	0.08
RSI	42.35
Earnings Date	n/a

About CG MedTech

CG MedTech Co.,Ltd. researches, develops, manufactures, and sale of orthopedic medical devices in the healthcare service market. The company offers headless screws, cortex screws, and K-wires and pin; Aspiron and Maxima anterior cervical plate systems for use in anterior interbody screw/plate fixation of the cervical spine; ANAX OCT spinal system, a device for spinal surgery; Velofix PEEK SA cervical cages for cervical interbody fusion; and Velofix PEEK cage; and NeoIC PEEK cage, devices used with autograft or bone graft substitutes, as well as...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1993
• Employees: 120
• Stock Exchange: KOSDAQ
• Ticker Symbol: 056090

Financial Performance

In 2025, CG MedTech's revenue was 47.23 billion, an increase of 36.43% compared to the previous year's 34.62 billion. Earnings were 6.51 billion, an increase of 10801.84%.